Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy S Yu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinics in Liver Disease|September 26, 2003
Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant periodAndy S Yu, Emmet B Keeffe
The American Journal of Gastroenterology|June 18, 2003
Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?Andy S Yu, Emmet B Keeffe
Reviews in Gastroenterological Disorders|April 10, 2003
Management of hepatocellular carcinomaAndy S Yu, Emmet B Keeffe
Reviews in Gastroenterological Disorders|July 19, 2002
Nonalcoholic fatty liver diseaseAndy S Yu, Emmet B Keeffe
Clinics in Liver Disease|October 16, 2004
Hepatitis B vaccinesAndy S Yu, Ramsey C Cheung, Emmet B Keeffe
Infectious Disease Clinics of North America|March 11, 2006
Hepatitis B vaccinesAndy S Yu, Ramsey C Cheung, Emmet B Keeffe
Annals of Internal Medicine|September 24, 2004
"Wait-and-see": an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapyNeville R Pimstone, Daniel Pimstone, Theparat Saicheur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2024
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-AnalysisCalvin Q Pan, Lin Zhu, Andy S Yu, et al.
Digestive Diseases and Sciences|July 4, 2015
Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or TenofovirTse-Ling Fong, Andy Tien, Kahee J Jo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinics in Liver Disease|September 26, 2003
Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant periodAndy S Yu, Emmet B Keeffe
The American Journal of Gastroenterology|June 18, 2003
Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?Andy S Yu, Emmet B Keeffe
Reviews in Gastroenterological Disorders|April 10, 2003
Management of hepatocellular carcinomaAndy S Yu, Emmet B Keeffe
Reviews in Gastroenterological Disorders|July 19, 2002
Nonalcoholic fatty liver diseaseAndy S Yu, Emmet B Keeffe
Clinics in Liver Disease|October 16, 2004
Hepatitis B vaccinesAndy S Yu, Ramsey C Cheung, Emmet B Keeffe
Infectious Disease Clinics of North America|March 11, 2006
Hepatitis B vaccinesAndy S Yu, Ramsey C Cheung, Emmet B Keeffe
Annals of Internal Medicine|September 24, 2004
"Wait-and-see": an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapyNeville R Pimstone, Daniel Pimstone, Theparat Saicheur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2024
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-AnalysisCalvin Q Pan, Lin Zhu, Andy S Yu, et al.
Digestive Diseases and Sciences|July 4, 2015
Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or TenofovirTse-Ling Fong, Andy Tien, Kahee J Jo, et al.
Pageof 1